Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Authors
Laura Esserman•Donald Berry•Nola Hylton
Journal
Breast Cancer Research and Treatment
Published
December 24, 2011
Sign in to comment
Add a comment...
Supporters
Support the authors with ResearchCoin
Topics
DOI
License
cc-by-nc
No comments yet. Start the conversation!
Your contribution could help open science.